| Application no. and date | 20712029.6 (espacenet) (Federated) (European Patent Register), 20200302 | | Patent/reg. no. and date | DK/EP 3934637, 20240731 | | Publication date | 20220112 | | Priority no. and date | US 201962812987 P, 20190302, US 201962842296 P, 20190502, US 201962888894 P, 20190819, US 201962895144 P, 20190903 | | EP pub. no. and date |
EP 3934637 20220112 | | Effective date | | | Applicant/owner | IntraBio Ltd, Summit House
170 Finchley Road
London NW3 6BP, GB | | Applicant ref. no. | P85040DK01 | | Inventor | FACTOR, Mallory, 9 Hill Street
Mayfair W1J 5LF, GB,
FIELDS, Taylor, 9 Hill Street
Mayfair W1J 5LF, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/198 (2006.01) , A61P 29/00 (2006.01) | | Title | (N-)ACETYL-L-LEUCIN TIL ANVENDELSE TIL BEHANDLING AF TRAUMATISK HJERNESKADE | | Int. application no. | IB2020051767 | | Int. publication no. | WO2020178721 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
